Ory Rouvio
Impact in
- Hematology top 10%
- Multiple Myeloma Research and Treatments
-
- Chronic Lymphocytic Leukemia Research
- Myeloproliferative Neoplasms: Diagnosis and Treatment
Papers in
- Hematology 13
- Multiple Myeloma Research and Treatments 13
-
- Protein Degradation and Inhibitors 6
- Co-authors
- Yaël C. Cohen (9 shared papers)Tamar Tadmor (11 shared papers)Irit Avivi (9 shared papers)Moshe E. Gatt (9 shared papers)Hila Magen (7 shared papers)Noa Lavi (6 shared papers)Evgeni Chubar (4 shared papers)Chezi Ganzel (5 shared papers)
- Journals
- Blood (5 papers)Leukemia Research (2 papers)Vaccine (1 paper)Blood Advances (1 paper)International Journal of Molecular Sciences (1 paper)
- Partner nations
- IsraelUnited StatesGermany
In The Last Decade
Ory Rouvio
18 papers receiving 131 citations
Peers
Comparison fields: 5 of 35
- Hematology 70
- Genetics 32
- Oncology 39
- Molecular Biology 63
- Pathology and Forensic Medicine 14
Countries citing papers authored by Ory Rouvio
This map shows the geographic impact of Ory Rouvio's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ory Rouvio with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ory Rouvio more than expected).
Fields of papers citing papers by Ory Rouvio
This network shows the impact of papers produced by Ory Rouvio. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ory Rouvio. The network helps show where Ory Rouvio may publish in the future.
Co-authors
The 25 scholars most cited alongside Ory Rouvio, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 21 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2015 | 33 | |
| 2 | 2020 | 18 | |
| 3 | 2020 | 14 | |
| 4 | 2022 | 11 | |
| 5 | 2005 | 11 | |
| 6 | 2018 | 10 | |
| 7 | 2018 | 9 | |
| 8 | 2018 | 6 | |
| 9 | 2019 | 5 | |
| 10 | 2020 | 4 | |
| 11 | 2016 | 3 | |
| 12 | 2019 | 2 | |
| 13 | 2018 | 1 | |
| 14 | 2016 | 1 | |
| 15 | 2015 | 1 | |
| 16 | 2013 | 1 | |
| 17 | 2020 | 1 | |
| 18 | 2017 | 1 | |
| 19 | 2022 | 1 | |
| 20 | 2025 | 0 |
About Ory Rouvio
Ory Rouvio is a scholar working on Hematology, Molecular Biology, Genetics, Pathology and Forensic Medicine and Oncology, having authored 21 papers that have together received 133 indexed citations. Recurring topics across this work include Multiple Myeloma Research and Treatments (13 papers), Protein Degradation and Inhibitors (6 papers), Lymphoma Diagnosis and Treatment (6 papers), Chronic Lymphocytic Leukemia Research (6 papers), Immunotherapy and Immune Responses (3 papers), Viral-associated cancers and disorders (2 papers), Immune Cell Function and Interaction (2 papers) and CAR-T cell therapy research (2 papers). The work is most often cited by research in Hematology (70 citations), Genetics (32 citations), Oncology (39 citations), Molecular Biology (63 citations) and Pathology and Forensic Medicine (14 citations). Ory Rouvio has collaborated with scholars based in Israel, United States and Germany. Frequent co-authors include Yaël C. Cohen, Tamar Tadmor, Irit Avivi, Moshe E. Gatt, Hila Magen, Noa Lavi, Evgeni Chubar, Chezi Ganzel, Tatyana Dvorkin and Adir Shaulov. Their work appears in journals such as Blood, Leukemia Research, Vaccine, Blood Advances and International Journal of Molecular Sciences.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.